Home Overview Press Room Blog Publications For Students about us
Search

About Stem Cell Research


Stem cells are undifferentiated cells that can develop into specialized tissue types. Researchers are investigating how to isolate and culture them, and control their differentiation, in the hope that they can be used to treat and understand a variety of diseases.

Stem cells can be derived from a number of cellular sources: adult, fetal, and placental tissues; umbilical cord blood; and embryos. Stem cells from these different sources have different properties.

Adult stem cells can be obtained from the bodies of adults and children, and until recently considered multipotent, which means that particular adult stem cells can develop into specific tissue types. Adult stem cells have been used in therapies such as bone marrow transplants for years.

Embryonic stem cells are found in early embryos. They are pluripotent, which means they can develop into all tissue types and be cultured as stem cell "lines." No therapies have been developed from human embryonic stem cells, which were first isolated in 1998.

In recent years, new methods of cellular reprogramming have enabled the derivation of so-called induced pluripitent stem (iPS) cells, which seem to have the full powers of embryonic stem cells but are from adult body cells.

Human embryonic stem cell research is controversial because it destroys embryos. Most investigations use embryos created but not used for in vitro fertilization (IVF) treatment. Some scientists have worked to derive human embryonic stem cells using a cloning technique called research cloning, which raises a separate set of troubling questions.



Still No Stem Cells Via Easy 'STAP' Pathby David CyranoskiNatureDecember 18th, 2014The Japanese stem-cell biologist whose papers caused a sensation earlier this year before being retracted has failed to replicate the controversial experiments.
Biopolitical News of 2014by Pete Shanks, Jessica Cussins & Marcy DarnovskyBiopolitical TimesDecember 18th, 2014This is everything important that happened in biopolitics in 2014 (or close to it).
European Court Opens Door for Stem Cell PatentingGenetic Engineering & Biotechnology NewsDecember 18th, 2014The European Court of Justice ruled that human embryonic stem cell patents could be allowed if organisms can't develop into human being.
Top Biopolitical Times Posts of 2014by Jessica Cussins & Pete ShanksBiopolitical TimesDecember 18th, 2014In 2014, CGS staffers and contributors posted 107 blogs in Biopolitical Times. These are twelve of our favorites.
California Launches $50 Million, Fast-Track Stem Cell Driveby David JensenCalifornia Stem Cell ReportDecember 11th, 2014The California stem cell agency approved a plan that will radically reshape its efforts to produce a widely available stem cell treatment, a goal it has not yet reached after 10 years of trying.
Stem Cells: The Black Box of Reprogrammingby David CyranoskiNature NewsDecember 10th, 2014Scientists have been reprogramming adult cells into embryonic ones for decades — but they are only now getting to grips with the mechanics.
The NFL Has a Problem with Stem Cell Treatmentsby Antonio RegaladoMIT Technology ReviewDecember 10th, 2014Professional athletes are getting injections of stem cells to speed up recovery from injury. Critics call it a high-tech placebo.
Did NBC News Err On Key Part of Their Stem Cell Report?by Paul KnoepflerKnoepfler Lab Stem Cell BlogDecember 7th, 2014Overall this was a well-done report, but NBC made the bombshell claim that the FDA does not regulate unapproved stem cell “treatments.” This seems very difficult to believe.
New Interview with FDA on Key Stem Cell Regulatory Issues & Its Own Researchby Paul KnoepflerKnoepfler Lab Stem Cell BlogDecember 1st, 2014An interview with the FDA on key pressing stem cell issues, including Right To Try Laws, the agency's approach to dubious stem cell clinics, and its own research on stem cells.
UCLA Researchers Announce Gene Therapy Cure for 18 ‘Bubble Baby’ Patientsby Cath Becker and Suzan ClarkeGood Morning AmericaNovember 18th, 2014Researchers announced they have cured 18 children who were born with a genetic disorder that leaves them without a working immune system.
The Real Deal with Stem Cell Therapy in the PhilippinesThe Philippine StarNovember 17th, 2014There is a big difference between “magic potions” offered by unscrupulous clinics and the real scientific approach to stem cell therapy.
Evaluating California’s Stem Cell Experimentby David E. JensenSacramento BeeNovember 15th, 2014CIRM expects to be taking part in 10 early-stage clinical trials this year; however, no California-financed cures or therapies have reached the clinic and none are likely to do so for years.
Are All Pluripotent Stem Cells Equal?by Pete ShanksBiopolitical TimesNovember 12th, 2014A new paper by long-term advocates of research cloning implies that it has no advantage over reprogramming cells.
Scientists Find That SCNT Derived Cells and IPS Cells are SimilarNew York Stem Cell FoundationNovember 6th, 2014Cells derived from these two methods resulted in cells with highly similar gene expression and DNA methylation patterns and similar amounts of DNA mutations.
Can Scientists Patent Life? The Question Returns to the Supreme Courtby Michael HiltzikLos Angeles TimesOctober 31st, 2014The thorny and unresolved question of whether life itself can be patented may come again before the U.S. Supreme Court, if it accepts a motion filed by Santa Monica-based Consumer Watchdog.
Procedure on Paralyzed Man Stirs Hope and Cautionby Benedict CareyThe New York TimesOctober 21st, 2014The case of a Polish man who was paralyzed from the chest down until receiving a novel nerve-regeneration treatment has stirred as much excitement on the Internet as it has extreme caution among many experts.
Study Backs Use of Stem Cells in Retinas by Andrew PollackThe New York TimesOctober 14th, 2014Since they were first isolated 16 years ago, the progress of human embryonic stem cells has been slow, but now researchers are reporting an encouraging step.
Stem Cells for Diabetes: The Danger of the Word ‘Cure’by Paul KnoepflerKnoepfler Lab Stem Cell BlogOctober 13th, 2014Newspapers around the world widely exaggerated the potential impact of the recently reported production of insulin-secreting cells from human embryonic stem cells.
Stem Cell Treatments Surging Into Clinicby Bradley J. FikesUT San DiegoOctober 7th, 2014How the government, insurers and patients would pay for very expensive new stem cell therapies drew the attention of more than 700 biomedical and health-care executives at the 2014 Stem Cell Meeting on the Mesa.
Biotech Company Regeneus Under Fire For Saying AFL Approved Stem Cell Treatment, Claims Made to Patientsby Louise MilliganABCOctober 6th, 2014A listed company offering stem cell treatments to injured athletes is under fire for talking up the AFL's "approval" of its procedure and allegedly misleading the stock exchange.
Building a Superhuman: Stem Cell Advances are Leading to Dangers and Ethical Problems Few Have Considered[References CGS]by Joseph BreanNational PostOctober 3rd, 2014In last century’s nuclear age, mythical mutations were created by radiation. Now, all the promise and peril of human nature is wrapped up in stem cells.
Hwang Woo-suk Reaches the Silver Screenby Pete ShanksBiopolitical TimesOctober 2nd, 2014A new movie opening in Korea is explicitly about how the notorious cloning and stem-cell fraud was revealed, though the names of the principals have been changed.
Woman Receives First Stem Cell Therapy Using Her Own Skin Cellsby Alice ParkTimeSeptember 12th, 2014A Japanese woman is the first to receive retinal cells made from her own skin cells.
New Details Emerge on Retracted STAP Papersby David CyranoskiNature News BlogSeptember 11th, 2014New leaked e-mails showing the comments of referees for Science and Nature provide more insight into the saga of the STAP papers.
Revolving Door Policy Tightened at California Stem Cell Agency by David JensenCalifornia Stem Cell ReportSeptember 10th, 2014Directors of the California stem cell agency approved a measure aimed at easing conflicts of interest involving employees who may seek employment with recipients of the agency’s largess.
Next-Generation Stem Cells Cleared for Human Trialby David CyranoskiNatureSeptember 10th, 2014A Japanese patient with a debilitating eye disease is about to become the first person to be treated with induced pluripotent stem cells.
Stem cell industry's 'huge development' in Bay Areaby Stephanie M. LeeSan Francisco ChronicleAugust 29th, 2014Almost three years after Geron shut down the world's first clinical trial of a therapy using embryonic stem cells, a subsidiary of another Bay Area company is reviving the work.
Stem cell therapy a primitive artby Jill MargoFinancial ReviewAugust 27th, 2014A loophole in Australian regulations means people can be given stem cell therapy for virtually anything, providing their own stem cells are harvested and then used in the process. But much can go wrong.
Stem Cell Therapy Rogue Operators Charging Thousands for Useless or Dangerous Treatmentby Louise MilliganABCAugust 25th, 2014Rogue stem cell therapy operators are charging tens of thousands of dollars for treatments that are ineffectual or could even lead to more health problems and death, according to Australia's leading group of stem cell scientists.
Letter Campaign Sought to Pressure FDA Action on Stem Cell Clinicsby Elie DolginNature MedicineAugust 6th, 2014Unregulated stem cell clinics are proliferating throughout the US.
STAP Stem Cell Controversy Ends in Suicide for Japanese Scientistby Karen KaplanLos Angeles TimesAugust 5th, 2014Sasai had said he was 'deeply ashamed' of the stem cell studies that were retracted in July.
Stem Cell Treatment Warnings After Australian Woman Dies in Russiaby Bridie SmithSydney Morning HeraldJuly 28th, 2014Risks of unproven stem cell treatments include allergic reaction or rejection of the cells by the patient’s immune system and the development of cancer, both of which can be fatal.
California's Stem Cell Scandal Gets Worseby Michael HiltzikLos Angeles TimesJuly 18th, 2014Anyone who cares about the advance of medical science and about the promise of biotechnology should be dismayed by how badly the California stem cell agency has handled its latest conflict-of-interest scandal.
California Lawsuit Charges StemCells, Inc., with Putting Patients at Riskby David JensenCalifornia Stem Cell ReportJuly 16th, 2014A former senior manager at StemCells, Inc. has filed a lawsuit alleging that “deficiencies in the company's cell lines put patients at risk of infection or death during clinical trials.”
Injured Argentine Winger Angel Di Maria may be Resorting to Unproven Stem Cell Therapyby Lenny BernsteinWashington PostJuly 11th, 2014Get ready for another explosion of interest in stem cell therapy, a now familiar occurrence every time a famous athlete undergoes the treatment.
Shameful Conflicts of Interest Involving California's Stem Cell Agencyby Pete ShanksBiopolitical TimesJuly 9th, 2014The former President of CIRM just took a job on the board of a company that benefited from the agency's grants, highlighting the conflicts of interest that have always bedeviled the agency.
Stem Cell Treatment Causes Nasal Growth in Woman's Backby Clare WilsonNew ScientistJuly 8th, 2014A woman in the US has developed a tumour-like growth eight years after a stem cell treatment to cure her paralysis failed.
Former CEO of California Stem Cell Agency Named to Board of Firm that Received $19 Million From the Agencyby  David JensenCalifornia Stem Cell ReportJuly 7th, 2014Alan Trounson has been named to the board of a company that has received $19.4 million from the agency he recently headed, raising fresh and serious questions about conflicts of interest at the state-funded research program.
On Meta-Research and the STAP Fiascoby Pete ShanksBiopolitical TimesJuly 7th, 2014The authors of the ballyhooed STAP papers have reluctantly agreed to retract them; meanwhile Stanford is launching a project to investigate the process of research.
Research Integrity: Cell-Induced Stressby David CyranoskiNature NewsJuly 3rd, 2014Two papers that offered a major breakthrough in stem-cell biology were retracted mired in a controversy that has damaged the reputation of several Japanese researchers.
Review of Mitalipov Group Nature Paper: Cloned ES Cells Versus iPS Cellsby Paul KnoepflerKnoepfler Lab Stem Cell BlogJuly 2nd, 2014Given the power, flexibility, and relative ease of making iPS cells, is there good reason to go to all that trouble to make NT ES cells?
Banking on iPSCsby Kerry GrensThe ScientistJune 30th, 2014A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
Hype and Hope: Illuminating the Reality of Stem Cell Treatments[Quotes Biopolitical Times contributor Pete Shanks]by David JensenCalifornia Stem Cell ReportJune 27th, 2014Several recent efforts from within the stem cell community highlight the risks of dubious, expensive stem cell treatments that are being offered domestically and internationally.
Selling Stem Cells Honestlyby Pete ShanksBiopolitical TimesJune 25th, 2014Scientists around the world are campaigning in favor of sensible regulation of stem-cell therapies. It’s about time.
Who Owns Your Tissue? You’d be Surprisedby Timothy CaulfieldToronto Globe and MailJune 20th, 2014Human tissue is a form of personal property. Not only that, once it is removed from a patient, it is owned by the hospital.
Regulation: Sell Help not Hopeby Paolo Bianco & Douglas SippNatureJune 16th, 2014Stem cells are being used as a wedge in calls to allow unproven medical interventions onto the market.
Stem Cells: Taking a Stand Against Pseudoscienceby Elena Cattaneo & Gilberto CorbelliniNatureJune 16th, 2014A pharmacologist and a bioethicist working to protect patients from questionable stem-cell therapies share their experiences in the fight against predatory pseudoscience.
Jordan’s Stem-Cell Law Can Guide The Middle Eastby Rana DajaniNatureJune 11th, 2014The law bans payment for donations of stem cells and eggs, and says that modified and manipulated cells are not to be used for human reproduction.
Genetic Tests Suggest STAP Stem Cells ‘Never Existed’by David CyranoskiNature News BlogJune 3rd, 2014Does the phenomenon, known as stimulus-triggered acquisition of pluripotency, or STAP, exist? The answer, according to Japanese media reports on the results of genetic tests, is no.
Braggadacio, Information Control, and Fear: Life Inside a Brigham Stem Cell Lab Under Investigationby AnonymousRetraction WatchMay 30th, 2014A former research fellow writes, "[I]n spite of the efforts of ethical watchdogs, these are behaviors that science is selecting for with its current funding and publication mechanisms."
Spinal Cord, HIV Stem Cell Treatments Fundedby Bradley J. FikesUT San DiegoMay 29th, 2014A potentially groundbreaking trial to treat spinal cord injuries with tissue grown from human embryonic stem cells will resume, after being funded by the California's stem cell agency.
Stem Cells in Sports Medicineby Pete ShanksBiopolitical TimesMay 29th, 2014The use of adult stem cells in sports medicine is growing, although the evidence that they help post-operative recovery is anecdotal.
Embattled STAP Cell Scientist Obokata to Retract Research PaperThe Japan TimesMay 28th, 2014Haruko Obokata has agreed to retract one of two STAP cell research papers from Nature, but maintains she will not retract the other one.
Surprise: Stem Cells Help Mice with Multiple Sclerosis to Walkby Kirsten StewartThe Salt Lake TribuneMay 15th, 2014While attempting to better understand the common problem of stem cell rejection, a team of scientists in California may have found a new avenue for treating multiple sclerosis.
Scientists, Stem Cells and Self-Delusion?by Pete ShanksBiopolitical TimesMay 10th, 2014A very disquieting meta-analysis casts doubt on recent findings suggesting that bone marrow stem cells can help in treating heart disease.
State Stem Cell Agency Hasn't Lived up to its Hype[Quotes CGS's Marcy Darnovsky]by EditorialSan Francisco ChronicleMay 2nd, 2014How good should California taxpayers feel about the state stem cell institute's use of their $3 billion? The answer is a decidedly mixed one.
Transcendence: See it for its Cultural Relevance, Not its Plot Lineby Jessica CussinsBiopolitical TimesMay 1st, 2014Transcendence won’t win you over with its dialogue or love scenes, but it’s a great springboard for pondering what quickly approaching developments in artificial intelligence, synthetic biology, and regenerative medicine may actually mean for society.
Former Osiris President Chosen as New CEO at California's Stem Cell Agencyby David JensenCalifornia Stem Cell ReportApril 30th, 2014The new president of the $3 billion research enterprise has a strong private sector background that will become increasingly important as the agency pushes to commercialize.
Stem Cell Revival: The 1990s are BackNew ScientistApril 30th, 2014More than 17 years later, what worked in Dolly the sheep finally appears to be working in humans. But after endless hope, hype and failure, it is hard to feel there is anything brave or new in this line of research.
More Cloning and Even More Eggsby Pete ShanksBiopolitical TimesApril 30th, 2014For the third time in less than a year, human embryonic stem cells have been derived by cloning, underlining the need to establish federal prohibitions against human reproductive cloning and protections for women who provide their eggs for the research.
Doubts Over Heart Stem-Cell Therapyby Alison AbbottNatureApril 29th, 2014An analysis of clinical studies that use adult stem cells to treat heart disease has raised questions about the value of a therapy that many consider inappropriately hyped.
Policy: Regulate Embryos Made for Researchby Insoo HyunNatureApril 28th, 2014As technical barriers fall, the United States should adapt existing measures to govern the generation of human embryos for research.
State Stem Cell Agency’s at a Crossroadsby David JensenThe Sacramento BeeApril 28th, 2014In a few days, the $3 billion California stem cell agency is slated to pick a new president who will oversee what could be the last years of its life.
Stem Cells Made by Cloning Adult Humansby Monya BakerNatureApril 28th, 2014Two research groups have independently produced human embryonic stem-cell lines from embryos cloned from adult cells. But the technique is expensive, technically difficult and ethically fraught.
Top 5 Challenges for SCNT Cloned Human Embryonic Stem Cellsby Paul KnoepflerKnoepfler Lab Stem Cell BlogApril 21st, 2014A new advance in cloning to produce human embryonic stem cells is important because it shows it can be done using adult cells. However, key challenges and concerns remain.
Stem Cell Therapy Patient Dies at 23; Father Seeks Justiceby Stef dela CruzAll VoicesApril 4th, 2014Remaining mum about daughter Kate Tan's death in 2013, Bernard Tan finally decided to break his silence to expose his daughter's stem cell therapist, who is not a licensed physician.
New Hope for Embattled STAP Cell Researchers?by Monte MorinLos Angeles TimesApril 1st, 2014Just hours after Japanese investigators announced findings of fabrication and misconduct in a highly criticized "acid bath" stem cell study, scientists in Hong Kong said they had partly succeeded in reproducing the controversial experiment.
Stem Cell Scientists Reveal 'Unethical' Work Cultureby Helen ThomsonNew ScientistMarch 27th, 2014Some stem cell researchers responding to a New Scientist survey admitted to faked results, others told of unethical behaviour from superiors, and several placed the blame on high-profile journals.
Researchers Claim Stem Cell Advanceby Monte MorinThe Los Angeles TimesMarch 27th, 2014Researchers at Oregon Health and Science University say they have successfully generated embryonic stem cells using fertilized mouse embryos, a feat that many scientists had thought was impossible.
‘Stem Cell Tourism’ Takes Advantage of Patients, Says Law Professorby David TenenbaumUniversity of Wisconsin-Madison NewsMarch 24th, 2014Desperate patients are easy prey for unscrupulous clinics offering untested and risky stem cell treatments.
Stem Cell Guidelines Prohibit Research in Many Areas Including Human Germ Line Gene Therapy & Reproductive Cloningby Ramesh ShankarPharmaBizMarch 24th, 2014India's 'National Guidelines for Stem Cell Research' provide ethical and scientific directions to scientists and clinicians.
One Author of a Startling Stem Cell Study Calls for Its Retractionby Hiroko TabuchiThe New York TimesMarch 10th, 2014Saying he is no longer sure of his team’s conclusions, an author of a study that claimed to have discovered a simple new way to make stem cells has called for it to be retracted.
Critiquing the California Stem Cell Story: 'Continuums' vs. Curesby David JensenCalifornia Stem Cell ReportMarch 10th, 2014What cures has the California stem cell agency produced, as was promised during the 2004 ballot campaign that created the state program?
Efforts to Repeat Controversial Stem Cell Technique Intensifyby Carolyn Y. JohnsonThe Boston GlobeMarch 6th, 2014In an effort to bring clarity to one of the most controversial and confusing scientific findings in recent memory, three Japanese scientists have released a detailed protocol explaining step by step how to create stem cells with a simple acid bath.
Sequencing Pioneer's Startup Plans to Promote Better Agingby Elizabeth PennisiScienceMarch 4th, 2014J. Craig Venter has jumped into biomedical sequencing with his latest venture, Human Longevity Inc., "a genomics and cell therapy-based diagnostic and therapeutic company" that should be up and running by summer.
The Commercialization of Human Eggs in Mitochondrial Replacement Researchby Donna L. DickensonThe New Bioethics, Vol. 19, No. 1There has been a renewed campaign to legalize payment for eggs in research, although the actual scientific advances are at best modest.
Canadian Fashion Mogul Nygard Puts his Faith in Stem-Cell Science by Patrick WhiteThe Globe and MailFebruary 28th, 2014The 70-year-old founder of the Nygard fashion empire has turned his focus away from running the business and toward searching for everlasting life through stem-cell science.
Stem cell scientist gets suspended prison term by Nam Hyun-wooKorea TimesFebruary 27th, 2014The South Korean Supreme Court has upheld a suspended jail term for stem cell scientist Hwang Woo-suk, and ruled that Seoul National University’s dismissal of Hwang was justifiable.
New Stem Cell Sagasby Cynthia FoxBioScience TechnologyFebruary 25th, 2014The news on the “new stem cells” has been whiplash-inducing all month. Bad news followed good—followed bad.
Robert Klein, the California Stem Cell Agency and a $5 Billion Proposalby David JensenCalifornia Stem Cell ReportFebruary 23rd, 2014The California stem cell agency has put a little distance between it and its former chairman who is currently touting a new $5 billion bond measure to rescue the agency from its financial demise.
Opinions about scientific advances blur party-political linesby Matthew Nisbet and Ezra MarkowitzThe ConversationFebruary 19th, 2014We analysed a series of surveys to better understand what the US public thinks about stem cell research and how they formed these opinions, and were able to distinguish between the different factors influencing their beliefs.
Hwang's Patented Fraud and
New Questions about STAP Cells
by Pete ShanksBiopolitical TimesFebruary 19th, 2014Hwang Woo-suk is awarded a U.S. patent based on the work for which he was disgraced almost a decade ago; an investigation is launched into some apparently similar errors in the recent STAP cell papers.
Acid-Bath Stem-Cell Study Under Investigationby David CyranoskiNatureFebruary 17th, 2014A leading Japanese research institute has opened an investigation into a groundbreaking stem-cell study after concerns were raised about its credibility.
Disgraced Scientist Granted U.S. Patent for Work Found to be Fraudulentby Andrew PollackThe New York TimesFebruary 14th, 2014Korean researcher Hwang Woo-suk faked evidence of having created the world's first cloned human embryos, embezzled research funds and violated bioethics rules.
Why Easy Stem Cells Raise Hard Ethical Questionsby Brendan FohtThe Public DiscourseFebruary 11th, 2014A surprising new method for making stem cells offers scientists an easy alternative to destroying human embryos. But there is a disturbing possibility that the technique may create not stem cells but actual cloned embryos.
Stem Cell Lines Not Fit for Clinicby Kerry GrensThe ScientistFebruary 6th, 2014Most stem cell lines registered with the NIH don’t comply with the FDA’s guidelines for human use, according to a new report.
In a Pickle Over STAP Stem Cells: Top 5 Reasons for Skepticismby Paul KnoepflerKnoepfler Lab Stem Cell BlogFebruary 6th, 2014Extraordinary claims require extraordinary evidence and independent replication. STAP stem cells aren’t there…at least not yet.
Are STAP Stem Cells a Paradigm Changer? Hopes and Fearsby Pete ShanksBiopolitical TimesFebruary 6th, 2014Two papers published in Nature on January 30 describe a new and remarkably simple technique for generating cells that can, like embryonic stem cells, develop into many different kinds of cells.
Judges Side with FDA on Stem Cellsby Kerry GrensThe ScientistFebruary 6th, 2014A US federal appeals court maintains that stem cells proliferated in a lab must be regulated as a drug.
Extraordinary Stem Cell Method Tested in Human Tissueby Helen ThomsonNew ScientistFebruary 5th, 2014Hot on the heels of the news that simply dipping adult mouse cells in acid could turn them into cells with the potential to turn into any cell in the body, it appears that the same thing may have been done using human cells.
Global Patent War Looms With Epoch-Making Discovery of STAP Cellsby Tatsuyuki Kobori and Akiyoshi AbeThe Asahi ShimbunFebruary 3rd, 2014Japanese researcher Haruko Obokata's recent breakthrough in the creation of pluripotent stem cells in mice is set to trigger an all-out global patent war.
Stem Cell Timeline: The History of a Medical Sensationby Andy CoghlanNew ScientistJanuary 30th, 2014Human embryonic stem cells have attracted controversy since they were first grown in the lab. This timeline takes you through the ups and downs of the stem cell rollercoaster.
Stanford Consortium Wins $40 Million to Create Stem Cell Genomics Centerby David JensenCalifornia Stem Cell ReportJanuary 29th, 2014Directors of the California stem cell agency have approved a $40 million proposal ultimately targeted at creating medical treatments tailored to a patient's genetic makeup.
Stem Cell Breakthrough Could Reopen Clone Warsby EditorialNew ScientistJanuary 29th, 2014The ability to easily reprogram any cell to an embryonic state will inevitably bring out maverick human cloners. We shouldn't let them set the agenda.
Study Says New Method Could Be a Quicker Source of Stem Cellsby Andrew PollackThe New York TimesJanuary 29th, 2014A surprising study has found that a simple acid bath might turn cells in the body into stem cells that could one day be used for tissue repair and other medical treatments.
Whistle-Blower Breaks his Silenceby David CyranoskiNatureJanuary 28th, 2014A South Korean researcher reveals the fallout he faced after his tip-offs about cloning fraudster Woo Suk Hwang.
California’s stem cell agency poised to bet big on genomics researchby David JensenSacramento BeeJanuary 26th, 2014Directors of the California stem cell agency are preparing to create one or two stem cell genomic centers that they predict will make the state a world leader in the new field.
Editorial: Don’t rush to rehabilitate HwangNatureJanuary 21st, 2014Nature’s profile of a former fraudster’s attempts to regain respectability should not be taken as an endorsement of the researcher’s claims.
Cloning Fraudster Profiled by Big Science Journalsby Pete ShanksBiopolitical TimesJanuary 19th, 2014Korean stem-cell fraudster Hwang Woo-suk has been busy trying to rehabilitate his reputation and collaborating with the Chinese genomic powerhouse BGI.
Cloning comebackby David CyranoskiNature NewsJanuary 14th, 2014Ten years ago, Woo Suk Hwang rose to the top of his field before fraud and dodgy bioethical practices derailed his career. Can a scientific pariah redeem himself?
Doctor suspended for stem cell treatment by Nigel DuaraAssociated Press / Seattle Post IntelligencerJanuary 10th, 2014The Oregon Medical Board has issued a rare emergency suspension of a physician's license after the doctor conducted experimental stem cell treatments on patients, which the board considers an immediate danger to the public.
Scientific Concerns about Claims of Stem Cell "Cures"by Pete ShanksBiopolitical TimesJanuary 9th, 2014The most recent recurrence of stem cell mania is taking place in Italy, and there are problems worldwide.
Leaked Files Slam Stem-Cell Therapyby Alison AbbottNatureJanuary 7th, 2014Disclosures and resignations reveal scientific concerns over stem cell treatments conducted by Italy’s Stamina Foundation.
Claims of Stem Cell Cures by Clinic Chain, Stem.MDby Paul KnoepflerKnoepfler Lab Stem Cell BlogJanuary 6th, 2014One of the most concerning new trends in the stem cell arena is the explosive growth of chains of for-profit stem cell clinics in the US.
Gene Patent Case Fuels U.S. Court Test of Stem Cell Rightby Susan DeckerBloombergJanuary 5th, 2014As scientists get closer to using embryonic stem cells in new treatments for blindness, spinal cord injuries and heart disease, a U.S. legal debate could determine who profits from that research.
Dumbest Stem Cell Headlines & Stories of 2013by Paul KnoepflerKnoepfler Lab Stem Cell BlogDecember 23rd, 2013Reading these, one doesn’t know whether to laugh or cry.
Biopolitical News of the Year 2013by Pete ShanksBiopolitical TimesDecember 19th, 2013For better and worse, 2013 has been a year in which several related issues familiar to those who follow human biotechnology moved into the wider sphere of public discussion.
Sharp Exchanges as Stem Cell Board Tables Future Funding Proposalby David JensenCalifornia Stem Cell ReportDecember 11th, 2013A plan to finance the California stem cell agency after its $3 billion runs out in 2017 was shunted aside today after it ran into sharp opposition and questions from several of the agency's governing board members.
The California Stem Cell Agency: A Blueprint for Living Without $300 Million a Yearby David JensenCalifornia Stem Cell ReportDecember 5th, 2013The likely future of the $3 billion California stem cell agency is an enterprise no longer tied to state funding and much more closely linked with industry.
Puzzling Institute of Medicine Stem Cell Workshopby Paul KnoepflerKnoepfler Lab Stem Cell BlogNovember 13th, 2013The meeting title suggests, perhaps by accident, that there is a legitimate pathway to making unregulated therapies safe and effective. There isn't.
Philanthropist's Gift a Big Bang for Stem Cell Researchby Jon WalkerUSA TodayNovember 13th, 2013A philanthropist who made his money as a credit card provider is giving $100 million to UC San Diego for human stem cell research.
The Future of the California Stem Cell Agency: Cures, Priorities and Brain Drain by David JensenCalifornia Stem Cell ReportNovember 3rd, 2013The California stem cell agency is nearing the end of its “normal” life span, and the topic of its future comes up with some regularity nowadays within the Golden State's stem cell community.
Stem Cell Person of the Year 2013: Elena Cattaneoby Paul KnoepflerKnoepfler Lab Stem Cell BlogOctober 30th, 2013Beyond her great achievements in stem cell science, she has a track record of taking important public stands on key issues over the years.
An Insider’s Antidote for Dangerous Stem Cell Hypeby Bernadette TanseyXconomyOctober 22nd, 2013Paul Knoepfler’s new book is a scientific primer and a paean to the promise of stem cell research, but also a warning to vulnerable patients who prematurely look to stem cell therapy as a last-ditch hope for a cure.
Zeroing in on Therapies at the California Stem Cell Agencyby David JensenCalifornia Stem Cell ReportOctober 9th, 2013Directors of the California stem cell agency mull over a recommendation to focus intensely on a handful of research projects most likely to result in commercializing a stem cell therapy.
California's $70 Million Alpha Stem Cell Clinic Plan Edging Forward by David JensenCalifornia Stem Cell ReportSeptember 30th, 2013The California stem cell agency predicts that “human healthcare will be greatly improved” by stem cell research by 2024 and is fleshing out an ambitious plan to help make that happen.
Unlicensed Doctor who 'Sold Hope to Patients who had None' Sentencedby Jeff GermanLas Vegas Review-JournalSeptember 24th, 2013An unlicensed physician described as a "modern-day Dr. Frankenstein" was sentenced to federal prison for defrauding chronically ill patients through a phony stem cell implant procedure.
UC Davis Stem Cell Researcher Warns Consumers to Beware of Unproven or Dangerous Stem Cell Treatmentsby David JensenThe Sacramento BeeSeptember 15th, 2013Paul Knoepfler is a rare stem cell researcher who regularly explores the most problematic aspects of stem cell therapies on the Internet in full public gaze.
No Point in Testing Controversial Stem Cell Treatment, Italian Panel Saysby Laura MargottiniScienceSeptember 12th, 2013An expert panel of Italian scientists has concluded that a controversial stem cell therapy, a focus of intense public debate, has no scientific foundation.
Stem Cells Created in Living Miceby Heidi LedfordNatureSeptember 11th, 2013Researchers have reprogrammed adult mouse cells to behave like embryonic stem cells that can take on a wider variety of identities, without removing those cells from their natural environment.
Stem-Cell Banks Enable Wealthy to Free 'Backup Version' of their Adult Selvesby Andrew CaveThe TelegraphSeptember 9th, 2013Forget prestige cars, yachts and private jets. From tomorrow, British business executives, sports stars, celebrities and anyone else with £38,400 to spare will be able to freeze a backup of their adult selves for potential use decades later.
Stem Cell Treatments Overtake Scienceby Laura BeilThe New York TimesSeptember 9th, 2013The lack of proven safety or efficacy for stem cell treatments hasn't slowed the rise of an international industry catering to customers who may pay tens of thousands of dollars in cash for their shot at a personal miracle.
California Controversy: Let's Not Expand the Market in Women's Eggsby Marcy Darnovsky and Susan Berke FogelHuffington PostSeptember 3rd, 2013California Governor Jerry Brown's veto of a bill that would have allowed researchers to pay women for having their eggs harvested was warmly welcomed by women's health and public interest groups.
Scientists Grow Mini Brains From Stem Cellsby Elizabeth LandauCNNAugust 29th, 2013Scientists have used stem cells to create what they are calling "cerebral organoids" - pea-sized structures made of human brain tissue that may help explore brain development and disorders.
Stem Cells: Egg Engineersby David CyranoskiNatureAugust 21st, 2013In a technical tour de force, Japanese researchers created eggs and sperm in the laboratory. Now, scientists have to determine how to use those cells safely — and ethically.
Whose Stem Cells are They Anyway?by EditorialNew ScientistAugust 13th, 2013Patients are right to question government control of their body parts. It’s time for a shake-up.
Could it be a 'Cure'? Breakthrough Prompts Down Syndrome Soul-Searchingby JoNel AlecciaNBC NewsAugust 11th, 2013Hailed as a “cure in a Petri dish,” the research that may help create new treatments for problems caused by Down syndrome also raises the prospect of eliminating the condition entirely.
Stem Cells: What Happened to the Radical Breakthroughs?by Simon RoachThe GuardianAugust 10th, 2013Much was promised in the late 1990s, but advances such as growing whole human organs has been difficult to deliver.
Where’s the Beef? Reality Check on Test Tube Burger Baloneyby Paul KnoepflerKnoepfler Lab Stem Cell BlogAugust 7th, 2013What is the deal with the crazy hullaballoo over the so-called stem cell test tube burger?
The Henrietta Lacks Story and Eggs, Money and Motherhood[Quotes CGS's Diane Tober]by David JensenCalifornia Stem Cell ReportAugust 7th, 2013The legacy of Henrietta Lacks should resonate within the stem cell industry, as well as with Governor Brown, who has a bill on his desk to permit women to sell their eggs for research.
Race Matters When a Patient Needs a Stem Cell or Marrow Transplantby Arthur AllenWashington PostAugust 5th, 2013If you become ill with a blood cancer or other disease that requires a stem cell transplant, here’s an uncomfortable fact: Your race matters. Diversity is a strength in much of life, but it’s a curse when finding a stem cell donor match.
A Lab-Grown Burger Gets a Taste Testby Henry FountainThe New York TimesAugust 5th, 2013A hamburger made from bovine stem cells was fried, served and eaten in London in an odd demonstration of one view of the future of food. The $325,000 project was paid for by Google founder Sergey Brin.
Man Pleads Guilty in Stem Cell Schemeby Mike GlennThe Houston ChronicleJuly 31st, 2013On Wednesday, 42-year-old Vincent Dammai of South Carolina pleaded guilty in federal court in Houston for his role in stem cell fraud.
Japan to Start Stem-Cell Study on Humansby David CyranoskiNatureJuly 30th, 2013Researchers in Kobe, Japan will start recruiting patients for the world’s first clinical study using induced pluripotent stem cells.
Stem Cell Agency Approves Plan for Clinical Trial Networkby Karen KaplanLos Angeles TimesJuly 26th, 2013The governing board of the California Institute for Regenerative Medicine approved a $70-million plan to develop a network of clinics for conducting trials of experimental stem-cell therapies.
California Stem Cell Agency Delays Decision on Expanding the Market in Women’s Eggsby Marcy DarnovskyBiopolitical TimesJuly 25th, 2013The push by the stem cell agency’s leadership is one of two efforts to gut protections for women in California who provide eggs for research.
A Few Notes on the Invisibleby George Estreich, Biopolitical Times guest contributorJuly 23rd, 2013Thoughts about disability, invisibility, Ethan Saylor's death at the hands of private police, and news that the extra chromosome that causes Down syndrome may one day be “silenced.”
Controversial Korean Stem Cell Powerhouse in Big Trouble?by Pete ShanksBiopolitical TimesJuly 22nd, 2013RNL Bio, the controversial Korean biotechnology company, is undergoing some major changes. Its former CEO is under arrest for insider trading, its subsidiaries are going bust and the parent company is being delisted from the stock exchange. But it's still relying on the stem cell business to pull it through.
'Big Leap' Towards Curing Blindness in Stem Cell StudyBBC NewsJuly 21st, 2013An animal study at University College London showed the part of the eye which actually detects light can be repaired using stem cells.
World’s First Human Stem Cell Clinical Trial Approved by Japanese Governmentby Ida TorresJapan Daily PressJuly 19th, 2013Scientists will try replacing the damaged part of the eye with retinal cells created from induced pluripotent stem cells created from the patient's own body.
Stem Cells Reprogrammed Using Chemicals Aloneby David CyranoskiNatureJuly 18th, 2013Scientists have demonstrated a new way to reprogram adult tissue to become cells as versatile as embryonic stem cells without the addition of extra genes that could increase the risk of dangerous mutations.
Don’t Market Stem-Cell Products Ahead of Proofby Paolo BiancoNatureJuly 17th, 2013The controversy over an unproven stem-cell therapy in Italy highlights the dangers of doing translational medicine in reverse.
Researchers Turn Off Down’s Syndrome Genesby Beth MoleNatureJuly 17th, 2013Silencing extra chromosome in cell cultures could lead to new treatments for the disorder.
Viewpoints: Risks are Many in Paying Women to Donate Eggsby Diane Tober and Nancy Scheper-HughesThe Sacramento BeeJuly 16th, 2013As scientists in California delve more deeply into stem cell research and reproductive science, it is essential that women donating their eggs for research not be exploited or put at risk. A bill on the governor's desk would do just that.
RNL Bio’s CEO, Dr. Jeong Chan Ra, is Arrested and Charged with Insider Trading by Leigh TurnerHealth in the Global VillageJuly 12th, 2013Prosecutors are also reportedly investigating possible improprieties in the transfer of funds related to RNL Bio’s business operations in the United States with Texas-based Celltex Therapeutics.
Veto Campaign Launched on California Pay-for-Eggs Bill[Quotes CGS's Diane Tober]by David JensenCalifornia Stem Cell ReportJuly 12th, 2013Opponents of the California pay-for-eggs bill have kicked off a campaign to urge Gov. Jerry Brown to veto the industry-backed legislation.
Brown Ponders Sale of Women's Eggs For Research[Quotes CGS's Diane Tober]by Alex MatthewsCapitol WeeklyJuly 10th, 2013Egg providers "are treated as vendors, not as patients. They’re just shuttled out; no records are kept of the impact on women's health."
Trial and Errorby EditorialNatureJuly 9th, 2013Italian officials should not go ahead with expensive clinical tests of an unproven stem-cell therapy that has no good scientific basis.
Eggs and Cash: Stem Cell Agency Considering Easing Restrictions on Stem Cell Lines Derived Using Paymentsby David JensenCalifornia Stem Cell ReportJuly 7th, 2013The California stem cell agency is moving to remove a ban on using stem cell lines derived from eggs from women who have been paid to provide them.
Paper Raises Hundreds Of Questions About The Integrity Of Stem Cell Research Groupby Larry HustenForbesJuly 2nd, 2013A recent report details a multitude of discrepancies and contradictions in papers from a well-established German stem cell research group.
Too Much of a Rush for Clinical Trials With iPS CellsThe Asahi ShimbunJune 28th, 2013The world’s first clinical application of iPS cell technologies for humans has just got the go-ahead, but the safety of the technology, much less its effectiveness, has yet to be confirmed.
First Clinical Trial With Induced Pluripotent Stem Cells Grows Closerby Dennis NormileScienceJune 26th, 2013A Japan Ministry of Health, Labour and Welfare panel has accepted a plan to carry out what would be the world's first clinical trials involving induced pluripotent stem cells.
Should Women Make a Profit on Donating Their Eggs For Research? [With CGS's Diane Tober]by Larry MantleKPCCJune 20th, 2013The amount of money a woman can receive for donating eggs for research in California could shoot up from hundreds of dollars to thousands if a new law passes the state Senate.
Japan to Relax Ban on Chimeric Embryo Experimentsby Dennis NormileScienceJune 19th, 2013A scientist pioneering research toward generating human organs in pigs has cleared one hurdle in Japan, but is concerned that finalizing guidelines will take too long, so is considering conducting key experiments in the United States.
Inside the Stem Cell Shell Gameby Gina Maranto, Biopolitical Times guest contributorJune 18th, 2013Sociologist Ruha Benjamin examines the California stem cell initiative from a social justice perspective.
Self-Confessed Liar Publishes More Dubious Stem-Cell Workby David CyranoskiNatureJune 14th, 2013Hisashi Moriguchi, known for falsely claiming to have transfered induced pluripotent stem cells into patients, has published three papers in the past two months, again with dubious claims.
Real-Life True Blood: Synthetic Blood Is Coming — And So Are a Host of Potential Complicationsby Devon MaloneyWiredJune 14th, 2013Researchers at the Scottish Centre for Regenerative Medicine got the go-ahead late last month to start developing synthetic blood with adult stem cells.
Update: California Bill Would Overturn Protections for Women Providing Eggs for Research by Diane ToberBiopolitical TimesJune 13th, 2013If the bill is approved by the full Senate and signed into law by the governor, California researchers would be permitted for the first time to pay women for their eggs.
Cloning for Stem Cells: Controversy, Againby Jessica CussinsBiopolitical TimesMay 30th, 2013Errors have been found and acknowledged in the recent paper on the creation of stem cells through cloning – a reminder that questions about the utility and risks of research cloning go deeper than “careless” duplication of images.
Stroke Patients See Signs of Recovery in Stem-Cell Trialby Pallab GhoshBBC NewsMay 27th, 2013In one of the first clinical trials in the world to test the use of stem cells, five seriously disabled stroke patients have shown small signs of recovery following the injection of stem cells into their brain.
Editorial: More Conflicts Come to Light at Stem Cell InstituteThe Sacramento BeeMay 25th, 2013With a new chairman, the California Institute for Regenerative Medicine claims it has turned a page, but serious conflicts continue to be revealed.
Panel on the Ethics of New Stem Cell Cloning Method [VIDEO][With CGS's Marcy Darnovsky]China Central TelevisionMay 23rd, 2013Anchor Anand Naidoo joins Marcy Darnovsky of the Center for Genetics and Society and Jeffrey Karp from the Harvard Stem Cell Institute to talk about the controversy surrounding a recent study involving cloning techniques to produce human stem cells.
Stem-Cell Cloner Acknowledges Errors in Groundbreaking Paperby David Cyranoski & Erika Check HaydenNatureMay 23rd, 2013A blockbuster paper that reported the creation of human stem-cell lines through cloning has come under fire.
Grant Reviewer Conflict in $40 Million Round at California Stem Cell Agencyby David JensenCalifornia Stem Cell ReportMay 21st, 2013Internationally renowned scientist Lee Hood violated the California stem cell agency's conflict of interest policies when he was involved in reviewing applications.
Back to the Future: Cloning Human Stem Cells [VIDEO]Al JazeeraMay 17th, 2013Three commentators, including a scientist who previously supported research cloning, agree that the availability of less controversial alternatives for producing disease-specific and patient-specific stem cells makes this approach unnecessary.
Cloning, Stem Cells Long Mired In Legislative Gridlock[Quotes CGS's Marcy Darnovsky]by Julie RovnerNPRMay 16th, 2013The news that U.S. scientists have successfully cloned a human embryo seems almost certain to rekindle a political fight that has raged, on and off, since the announcement of the creation of Dolly the sheep in 1997.
US Scientists With Cloning Techniques Created Human Embryonic Stem Cells[Quotes CGS's Marcy Darnovsky]MercoPressMay 16th, 2013Stem cells have been a research focus for more than a decade because they can morph into any type of cell, potentially leading to treatments to replace damaged cells and organs. But along with the promise of the technology has come ethical questions and worry over human clones.
Scientists Create Human Stem Cells Through Cloningby Sharon BegleyReutersMay 15th, 2013After more than 15 years of failures by scientists around the world and one outright fraud, biologists have finally created human stem cells by the same technique that produced Dolly the cloned sheep.
Stem Cells Recovered From Cloned Human Embryos[Quotes CGS's Marcy Darnovsky]by Malcolm RitterAssociated PressMay 15th, 2013One expert called the work a landmark, but noted that a different, simpler technique now under development may prove more useful.
Precision StemCell: Selling Stem Cells & Treating Individuals With ALS as Human Guinea Pigsby Leigh TurnerHealth in the Global VillageMay 6th, 2013Unproven stem cell interventions offered internationally tend to gain media attention, but Precision StemCell, based in Alabama, is one example of a domestic clinic marketing stem cell interventions that appear to violate federal regulations.
California Lawmakers Consider Paying Women to Provide Eggs for Researchby Diane ToberBiopolitical TimesMay 2nd, 2013A new bill claims to be motivated by concerns for women’s equity and for advancing responsible medical research, but in fact undermines both.
As iPS Cell Studies in Humans Approach, Accessible Relevant Pre-Clinical Data Remains Minimalby Paul KnoepflerKnoepfler Lab Stem Cell BlogApril 19th, 2013We all want to get stem cell-based medicines to patients who need them as soon as possible, but there is such a thing as moving too quickly.
Which Comes First: The Woman or Her Eggs? [Quotes CGS's Marcy Darnovsky]by Ruha BenjaminHuffington PostApril 17th, 2013If we're going to support a "right to stem cell research," then we need to guarantee a right to health in the form of serious investment in egg donor safety.
Should researchers pay for women's eggs?[Op-Ed]by Ruha BenjaminSan Francisco ChronicleApril 4th, 2013Could compensation induce women of modest means to undergo the risks of egg extraction?
Stem-Cell Ruling Riles Researchersby Alison AbbottNatureMarch 26th, 2013The Italian health minister’s support for an unproven stem cell treatment appalls the country’s scientists.
UCSF Discovery a Potential "Earthquake" for Stem Cell Therapiesby Ron LeutySan Francisco Business TimesMarch 4th, 2013A new type of stem cell may open new possibilities for fixing damaged parts of the body.
Stem Cells Cruise to Clinicby David CyranoskiNatureFebruary 27th, 2013A Japanese researcher is seeking approval for the first clinical study of induced pluripotent stem cells.
Critiquing the Stem Cell Board[Editorial]Los Angeles TimesFebruary 27th, 2013California's stem cell institute is finally making some changes, but the modifications are more a bandage than a cure. Like a bandage, they will probably do, but only for a limited time.
Billionaires Anoint Biogeeksby Matthew HerperForbesFebruary 20th, 2013A group of Silicon Valley billionaires announced awards of $3 million to each of eleven recipients, in the first round of their "Breakthrough Prize in Life Sciences."
Embryo-Like Stem Cells Enter First Human Trialby David CyranoskiNatureFebruary 14th, 2013The clinical study in Japan will be the first to put induced pluripotent stem cells into humans.
Stem Cells in Texas: Cowboy Cultureby David CyranoskiNatureFebruary 13th, 2013By offering unproven therapies, a Texas biotechnology firm has sparked a bitter debate about how stem cells should be regulated.
Did Sperm and Egg Donors Unwittingly Contribute to NIH-Approved Stem Cells?by Jocelyn KaiserScienceInsiderFebruary 7th, 2013A review of the human embryonic stem cell lines approved by the National Institutes of Health has found that some of the cells may have come from sperm or egg donors who didn't consent to having their cells used in research.
Scientists Use 3-D Printer to Speed Human Embryonic Stem Cell Researchby Larry GreenemeierScientific AmericanFebruary 4th, 2013A team of scientists reports a breakthrough in 3-D printing using human embryonic stem cells that could purportedly lead to life-like bioengineered tissue and, eventually, artificial organs tailor-made for specific patients.
Controversial Stem-Cell Company Moves Treatment Out of the United StatesCelltex to send patients to Mexico.by David CyranoskiNatureJanuary 30th, 2013Celltex Therapeutics will now follow in the footsteps of many other companies offering unproven stem-cell therapies and send its patients abroad for treatment.
State Stem Cell Agency Endorses Conflict Guidelinesby Bradley FikesUT San DiegoJanuary 23rd, 2013California’s $3 billion state stem agency voted Wednesday to accept in concept proposed changes to reduce conflicts of interest on the agency's governing committee.
A Dangerous Game: Some Athletes Risk Untested Stem Cell Treatments by Deborah FranklinScientific AmericanJanuary 16th, 2013Some professional athletes' enthusiasm for certain stem cell treatments outpaces the evidence.
Moore is LessWhy the Development of Pluripotent Stem Cells Might Lead Us to Rethink Differential Property Interests in Excised Human Cellsby Osagie K. Obasogie and Helen TheungStanford Technology Law ReviewJanuary 15th, 2013A proposal for addressing the profound legal issues raised by induced pluripotent stem cells.
Safety of Induced Stem Cells Gets a Boostby Monya BakerNatureJanuary 9th, 2013A new paper could renew hopes of turning a patient’s own cells into perfectly matched replacement tissues, though differences in methodology between the study and clinical practice have left some eager for more proof.
Stem Cell Research Center Needs Overhaul, IOM Panel Says[Quotes CGS's Marcy Darnovsky]by Marcia FrellickAmerican Medical NewsJanuary 8th, 2013A report says board members must be free of personal and professional conflicts of interest. It also calls for an external scientific advisory board.
Stem Cell Lawsuit Finally Overby Jocelyn KaiserScience InsiderJanuary 7th, 2013The Supreme Court has rejected a request to ban federally funded research on human embryonic stem cells, bringing an end to a long legal battle.
RNL Bio Smuggled Out Stem Cellsby Yun Suh-youngThe Korea TimesJanuary 3rd, 2013RNL Bio sent 15.5 billion won worth of stem cells to hospitals in China and Japan on 860 different occasions from November 2008 through July 2012 without reporting the shipments.
Stem Cell Showdown: Celltex vs. the FDAby Susan BerfieldBloomberg BusinessweekJanuary 3rd, 2013The FDA has approved only one stem cell product and wrote a scathing report on Celltex, the Texan company that nonetheless continues to offer its controversial services.
Desperate Patients Seek Stem-Cell 'Miracle,' but Scientists Warn of Hidden Dangersby Marcia Heroux PoundsSun SentinelJanuary 3rd, 2013The recent World Stem Cell Summit pointed to reports of deaths, tumors, lumbar punctures and other potential harm, as well as vulnerable people being conned out of thousands of dollars.
Genes, Cells and Brains by Hilary Rose and Steven Rose - Reviewby Steven PooleThe Guardian (UK)December 19th, 2012A fascinating, lucid and angry book; a strong exposé of the hype surrounding genetics and neuroscience.
In the Flesh: The Embedded Dangers of Untested Stem Cell Cosmetics by Ferris JabrScientific AmericanDecember 17th, 2012Unapproved procedures and skin care products endanger consumers and researchers hoping to conduct clinical trials for promising stem cell medicine.
Universities with Connections Win Most Stem Cell Money[Quotes CGS's Marcy Darnovsky]by Melody PetersenThe Orange County RegisterDecember 14th, 2012Repeated independent reviews of the California Institute for Regenerative Medicine have found that its board is rife with conflicts of interest.
Review: Bioethics: All That Matters by Donna Dickensonby Gina Maranto, Biopolitical Times guest contributorDecember 13th, 2012This lively and accessible guide to the ethical implications of biotechnology asks how the field promotes or undermines social equality.
Is California's Stem Cell Program Preparing to Waste $700,000?by Michael HiltzikLos Angeles TimesDecember 12th, 2012The California Institute for Regenerative Medicine formally received the Institute of Medicine's review report at its meeting today; several board members showed overt hostility to the panel's recommendations.
IOM Proposals for Overhaul at CIRM Win High Marks [Quotes CGS's Marcy Darnovsky]by David JensenCalifornia Stem Cell ReportDecember 7th, 2012Independent observers gave generally high marks to the Institute of Medicine's recommendations for major changes at the California stem cell agency.
Public Expectations and Reality of Stem Cell Therapies Translationby Alexey BersenevCell TrialsDecember 7th, 2012A just-published study indicates that public optimism about stem cell research and translation is largely unjustified and even delusional.
Report recommends changes to California stem cell agency's board, goals[Quotes CGS's Marcy Darnovsky]by Ron LeutySan Francisco Business TimesDecember 6th, 2012"If CIRM acquires new funds from industry sources or venture firms, it must recognize that it has ongoing obligations to the people of California."
Report says California’s taxpayer-funded stem cell agency needs a reorganization[Quotes CGS's Marcy Darnovsky]by Alicia Chang, Associated PressWashington PostDecember 6th, 2012“CIRM has not responded in a meaningful way to many previous public interest suggestions or to independent reviews. We hope the agency will not continue that pattern.”
Center for Genetics and Society applauds recommendations for improvements in oversight and governance of California stem cell agency; calls for additional changes[Press statement]December 6th, 2012Given the state’s budgetary problems and CIRM's shortcomings, it would be wrong to ask Californians to give it more public money.
IOM Recommends Sweeping Changes at California Stem Cell Agencyby David JensenCalifornia Stem Cell ReportDecember 6th, 2012A study by the Institute of Medicine recommended sweeping changes at CIRM to remove conflict of interest problems, clean up a troubling dual-executive arrangement and fundamentally change the nature of the governing board.
Professors Critique Stem Cell Medical Tourism by Steven S. LeeThe Harvard CrimsonNovember 29th, 2012A panel at the Harvard Law School discussed the ethics of the use of embryonic stem cells in the United States, critiquing its role in medical tourism and the lack of research to back up its claims.
Doctors Guilty in Stem Cell Fraud Caseby Nathan BacaKLAS-TV Las VegasNovember 28th, 2012A federal court found two Las Vegas doctors guilty on all counts of defrauding patients with bogus experimental stem cell treatments.
Pluristem: Second Patient With ‘Life-Saving’ Cells Died by David WainerBusiness WeekNovember 9th, 2012The "compassionate use" of experimental stem cell therapies is thrown into question as the death of the second of three patients is announced.
What Does It Mean When Athletes Get 'Stem Cell Therapy'?by Timothy CaulfieldThe AtlanticOctober 22nd, 2012Media cheerleading is misleadingly legitimizing the booming "stem cell tourism" industry.
Stem Cell Controversy #1: Celltex and the FDAby Pete ShanksBiopolitical TimesOctober 18th, 2012The FDA has warned Texas stem-cell treatment company Celltex, and the review board that approved its activities, that the company is illegally selling an unlicensed drug and violates good manufacturing practices.
Stem Cell Controversies #2, #3, and #4: Some Careers (But Not All) Seem to Be Immortalby Pete ShanksBiopolitical TimesOctober 18th, 2012Michael West and Thomas Okarma want to take back Geron; Glenn McGee seems to have moved to Europe; and a Japanese fraud's career is over.
Research Firm Reaped Stem Cell Funds Despite Panel's Adviceby Michael HiltzikLos Angeles TimesOctober 17th, 2012StemCells Inc. has had rather a charmed relationship with California's publicly funded stem cell program, with some $40 million in awards approved this year.
Stem-Cell Fraud Hits Febrile Fieldby David CyranoskiNatureOctober 16th, 2012As Hisashi Moriguchi's heart-treatment claims collapse, observers warn about the febrile nature of the iPS-cell field and caution against a rush to the clinic.
FDA Issues Warning to Sugar Land Stem Cell Companyby Todd AckermanThe Houston ChronicleOctober 16th, 2012The Food and Drug Administration has informed the Texas company involved in Gov. Rick Perry's adult stem-cell procedure that it is illegally marketing an unlicensed drug.
Neural Stem Cells Successfully Implanted into the Brains of Four Boysby Jon BardinLos Angeles TimesOctober 12th, 2012Scientists have performed the first successful neural stem cell transplant into the brains of four boys with Pelizaeus-Merzbacher disease.
The HealerHow Shinya Yamanaka Transformed the Stem-Cell War and Made Everyone a Winnerby William SaletanSlateOctober 9th, 2012Shinya Yamanaka's research on "induced pluripotent stem cells" earned him a Nobel Prize. But much of the media coverage missed half the story. Yamanaka’s venture wasn’t just an experiment. It was a moral project.
Japan Team Offers Fertility Hope with Stem Cell Eggsby Harumi OzawaJakarta GlobeOctober 6th, 2012Japanese scientists create mice using artificial eggs created from "normal" adult cells.
Stem Cell Cash Mostly Aids Directors' Interestsby David JensenThe Sacramento BeeSeptember 23rd, 2012The California stem cell agency's fresh set of funding awards renews debate about conflicts of interest.
A First: Organs Tailor-Made With Body’s Own Cellsby Henry FountainNew York TimesSeptember 15th, 2012Swedish doctors replace a man's cancerous windpipe with a new one made from plastic and his own stem cells.
Sperm Precursor Cells Created in Labby Michael CookBioEdgeSeptember 7th, 2012Scientists may soon be able to create artificial sperm from a skin cell. Proponents extol benefits for sterile men; opponents warn of future obsolescence of males.
US Stem Cell Scientist Punished for Fraudby Michael CookBioEdgeSeptember 7th, 2012A Harvard University researcher was recently disciplined by the Department of Health and Human Services for using images from other publications as her own.
A Legal Win for Stem Cell Research, but Case May Not Be Overby Jocelyn KaiserScienceAugust 24th, 2012A U.S. appeals court today upheld the legality of federally funded research on human embryonic stem cells — the latest in a string of wins for the National Institutes of Health.
Undetectable Stem Cell Treatment Could be the Wave of the Performance-Enhancement Futureby Eric AdelsonYahoo NewsAugust 24th, 2012Sports science is on the precipice of a potentially new era of performance enhancement: stem cell therapy, which could soon make testosterone injections as ancient as the typewriter.
Stem Cells: A Culture War Gone Quiet by Alex Seitz-WaldSalonAugust 23rd, 2012The GOP is so against stem-cell research that it's in the party platform. So why won't Republicans talk about it?
Ruling Frees FDA to Crack Down on Stem Cell Clinicsby Peter AldhousNewScientist.comJuly 25th, 2012It's official: stem cells are drugs. The US district court has ruled that the FDA has the authority to regulate clinics offering controversial stem cell therapies.
Patients Seek Stem-Cell Compensationby David CyranoskiNature NewsJuly 6th, 2012Six patients in California are suing RNL Bio, one of the world’s largest stem-cell companies, for allegedly misleading them about the effectiveness of its stem-cell treatments.
Should People be Allowed To Sell Their Organs?by Alice ParkTime / CNNJuly 3rd, 2012A U.S. Appeals Court has allowed donors to sell their bone marrow for up to $3,000. Could organs and other body parts soon carry a price tag as well?
How to Tell When A Drug Company Fibs About Clinical Trial Resultsby Adam FeuersteinThe StreetJuly 3rd, 2012Osiris Therapeutics "disappeared" important data when it announced results of a study of a stem cell therapy in heart attack patients.
Will the FDA Close Down Celltex? by Pete ShanksBiopolitical TimesJune 28th, 2012An FDA report itemizes 79 specific problems with the Texas stem-cell company Celltex, and more trouble may be on the way.
FDA Report Faults Houston Stem-Cell Companyby Todd AckermanHouston ChronicleJune 26th, 2012The company involved in Gov. Rick Perry's unlicensed adult stem-cell procedure is rife with basic manufacturing problems, according to the US Food and Drug Administration.
Informed Consent: A Broken Contractby Erika Check HaydenNature NewsJune 20th, 2012As large-scale genetic research has become faster and cheaper, more and more personal genetic data collected for one purpose ends up being used for another.
More Scandals in South Koreaby Pete ShanksBiopolitical TimesJune 8th, 2012Fresh accusations of stem-cell fraud, whose full extent is yet unknown, are rocking South Korea and threatening to damage the nation's reputation again.
Seoul National University Professor Suspected of Stem Cell Study Fabricationby Yi Whan-wooThe Korea TimesMay 29th, 2012A stem cell researcher in Korea is suspected of fabricating over a dozen studies submitted to academic journals.
In the News: Stem Cell Cash Will Run Out – Then What?by David JensenThe Sacramento BeeMay 20th, 2012Prop. 71 has previously provided a direct stream of state bond cash, but what will happen when, in about five years, the state stops borrowing money to finance stem cell research?
California Considers DNA Privacy Lawby Helen ShenNatureMay 18th, 2012California lawmakers are considering a bill that would require written consent for the collection, retention, and sharing of individual genetic information. Academic researchers fear the measures would prohibit work with genetic databases.
Bioeconomy in South Korea, Again by Pete ShanksBiopolitical TimesMay 15th, 2012South Korea is investing in the bioeconomy again, despite the scandals of the last decade.
South Korea Steps Up Stem-Cell Work by Soo Bin ParkNature NewsMay 1st, 2012In South Korea, regenerative medicine gets a cash boost. Some say stricter regulations are needed to ensure safety.
The Texas Two-Step: New State Regs Allow Stem Cell Companies to Circumvent FDA Evaluations by Daniel SharpBiopolical TimesApril 19th, 2012New regulations in Texas allow stem cell corporations to circumvent FDA review, raising concerns for health and safety.
Texas Board Approves Rules on Use of Stem Cellsby Minjae ParkNew York TimesApril 13th, 2012Amidst criticism, Texas approves controversial regulations for adult stem cells.
Critics of California Stem-Cell Agency Address Institute of Medicine Panel[Quote's CGS's Marcy Darnovsky]by Erika Check HaydenNature News BlogApril 13th, 2012Speakers raised concerns about built-in conflicts of interest, oversight by elected officials, and unfulfilled promises to voters.
Texas Accused of Ignoring FDA on Stem Cell Rulesby Todd AckermanHouston ChronicleApril 10th, 2012Texas' new adult stem cell regulations have drawn criticism for circumventing FDA standards and making questionable practices commercially available.
Statement to Institute of Medicine Committee on the California Institute for Regenerative Medicine by Marcy DarnovskyApril 10th, 2012Marcy Darnovsky of the Center for Genetics and Society made this statement before the Institute of Medicine Committee regarding CIRM's funding and governance structure.
At a Crossroads, California’s Stem Cell Agency Ponders a Future Without Taxpayer Support[Quotes CGS's Marcy Darnovsky]by Alicia ChangWashington PostMarch 18th, 2012Eight years have passed since the creation of California's stem cell agency, and the legacy CIRM will leave remains unclear.
FDA Receives Complaint About Houston Company that Stored Gov. Perry's Stem Cellsby Todd AckermanHouston ChronicleMarch 14th, 2012Is the stem cell company involved in Rick Perry's unregulated adult stem-cell operation a potential danger to patients, and not in compliance with federal law?
Texas Family Turned to Bonita Stem Cell Doctor, but 5-Year-Old Died Before 'Miracle' by Liz FreemanNaples NewsMarch 3rd, 2012Parents put their trust in experimental stem cell treatments that the Food and Drug Administration has not approved.
Stem Cell Fraud Is the Real Issue in Texasby Pete ShanksBiopolitical TimesMarch 2nd, 2012Bioethicist Glenn McGee has resigned from Celltex. His connection with the controversial stem-cell company has raised important issues about its business practices.
Controversial Bioethicist Quits Stem-Cell Companyby David CyranoskiNature News BlogMarch 1st, 2012In an announcement on his Twitter page, bioethicist Glenn McGee resigned his position at Celltex Therapeutics after a turbulent three months.
Editor’s Move Sparks Backlashby David CyranoskiNature NewsFebruary 21st, 2012Bioethicists are forced to consider their own ethics as a prominent figure in the field joins a controversial stem cell company.
Rick Perry, Glenn McGee and Selling Texas Stem Cellsby Pete ShanksBiopolitical TimesFebruary 16th, 2012Gov. Perry is actively promoting an industry based on adult stem cells, in which Glenn McGee, until recently editor of the American Journal of Bioethics, is now employed.
Stem Cell Banking: The Newest Lure in Medical TourismArab princes and U.S. celebrities fly in for futuristic bio-care at Seoul "Life Center" by Frances ChaCNNFebruary 2nd, 2012In a new form of medical tourism, people from around the world are traveling to Seoul for stem cell treatments and to bank their stem cells, hoping that this will one day save their lives.
Gingrich Vows to Ban Embryonic Stem-Cell Research, Questions In Vitro Practicesby Karen TumultyWashington PostJanuary 29th, 2012Gingrich makes clear that, if elected, he would ban embryonic stem-cell research.
ACT Publishes First, Tentative Results of Embryonic Stem Cell Trialby Pete ShanksBiopolitical TimesJanuary 25th, 2012Advanced Cell Technology released very limited but mildly promising preliminary results of its clinical trial, and convinced some, though not all, reporters to hype it.
California’s Stem Cell Agency “Stacks the Deck” at a Key Hearing by Marcy DarnovskyBiopolitical TimesJanuary 24th, 2012A meaningful review of the stem cell program by the Institute of Medicine could make an important contribution to needed changes at the agency.
Stacking the Deck on the Stem-Cell Programby Michael HiltzikLos Angeles TimesJanuary 21st, 2012The Institute of Medicine is poised to receive a one-sided picture of California's stem-cell program in their upcoming review.
S. Korea Approves Sales of New Stem Cell Drugby Associated Foreign PressMysinchew.com January 19th, 2012South Korea's government drug agency cleared the way for commercial sales of what it called the world's first approved medicine using stem cells, developed from newborns' cord blood.
60 Minutes Exposes Stem Cell Scams — Againby Pete ShanksBiopolitical TimesJanuary 10th, 2012For the second time in two years, 60 Minutes exposes a stem-cell scam and stresses that these are not isolated instances.
Stem Cell Fraud: A 60 Minutes Investigationby Scott Pelley60 MinutesJanuary 8th, 2012The Internet is full of websites selling unproven stem cell treatments for incurable illnesses. Correspondent Scott Pelley investigates.
Chimeric Monkeys Born in Stem Cell Studyby Dan VerganoUSA TodayJanuary 5th, 2012Biologists report the first monkey "chimeras," born from mixtures of very-early stage embryonic cells.
Stem cell research on donor eggs often not disclosedby Frederik JoelvingReuters HealthJanuary 3rd, 2012Many U.S. fertility clinics don't tell egg donors that embryos made from their eggs may end up being used in stem cell research, according to a new government survey.
American Scientist Arrested in Stem-Cell Clinic Stingby Ewen CallawayNature News BlogDecember 29th, 2011An American university scientist was arrested on 27 December, accused of supplying stem cells for use in unapproved therapies.
Mercury News editorial: Stem-Cell Institute Should Take a Bow (Out)by Mercury News EditorialSan Jose Mercury NewsDecember 17th, 2011It would be wrong to ask for more public financing from California.
Stem Cell Study: Govt Wants to Draw Ethical Lineby Durgesh Nandan JhaTimes of IndiaDecember 16th, 2011The Indian Council of Medical Research, in collaboration with the Department of Biotechnology, is seeking public opinion on gamete and embryo donation for stem cell research.
Ethics Concerns about Geron's Exit from the Stem Cell Businessby Pete ShanksBiopolitical TimesDecember 15th, 2011Some stem-cell scientists and bioethicists are critical of Geron's early termination of a clinical trial and willingness to include one last patient.
Hoping for Cures, Supporters May Back Another Ballot Measure for Stem Cell Agencyby Steve JohnsonSan Jose Mercury NewsDecember 8th, 2011California's $3 billion taxpayer-financed stem cell agency still has no treatments on the market and is now at a critical juncture that could determine how much longer it stays in operation.
California Stem Cell Agency Needs to Study Itself[Quotes CGS's Marcy Darnovsky]by Michael HiltzikLos Angeles TimesDecember 7th, 2011The California Institute for Regenerative Medicine has downplayed the recent exit from the stem cell field by Geron, but the fiasco raises questions about how the agency does business.
Court Says Some Donors of Stem Cells Can Be Paidby Andrew PollackNew York TimesDecember 1st, 2011An appeals court says a law prohibiting payment for donated organs did not apply to stem cells extracted from circulating blood.
Cloning Technology: Control the Bonanza for Research Eggs[Letter to the editor]by Marcy Darnovsky, Susan Berke Fogel, Judy NorsigianNatureDecember 1st, 2011The demand for women’s eggs for research could soar alarmingly following a report of a new cloning technique.
Economics, Not Science, Thwarts Embryonic Stem Cell Therapyby Eryn BrownLos Angeles TimesNovember 21st, 2011Geron Corporation has pulled the plug on its ambitious effort to reverse spinal damage and will focus instead on financially less risky cancer drugs.
The Economics of Stem Cell Research[audio; quotes Marcy Darnovsky]by Stephanie O'NeillThe Madeleine Brand ShowNovember 16th, 2011What role did exaggerated promises play in the decision?
Geron Quits the Embryonic Stem Cell Industryby Pete ShanksBiopolitical TimesNovember 16th, 2011Geron has cancelled its clinical trial of a stem-cell treatment for spinal cord injuries, raising questions about the future of the company and the industry.
First Test of Human Embryonic Stem Cell Therapy in People Discontinuedby Rob SteinThe Washington PostNovember 14th, 2011Geron, the company conducting the first FDA-approved clinical trial of human embryonic stem cells, abruptly announced that it was halting the study.
Oregon Health & Science University wins breakthrough stem-cell patent; ethics of cloning debatedby Nick BudnickThe OregonianNovember 2nd, 2011Over the long-term, observers say, it could lead to the genetic engineering of human beings. But OHSU's announcement yesterday focused on short-term health gains.
European Court of Justice: No Patents on Human Embryonic Stem Cells by Marcy DarnovskyBiopolitical TimesOctober 27th, 2011Greenpeace applauds the decision for limiting commercialization of the human body; a stem cell patent holder warns of disaster; a patent lawyer says the ruling may in fact encourage research.
Hwang Clones Coyotes, Scores Headlinesby Pete ShanksBiopolitical TimesOctober 19th, 2011Disgraced South Korean scientist Hwang Woo-Suk continues his efforts at rehabilitation by cloning endangered coyotes.
EU court: No patents for some stem cell techniquesby Maria ChengBloomberg BusinessweekOctober 18th, 2011The European Union's top court ruled Tuesday that scientists cannot patent stem cell techniques that use human embryos.
Gene therapy and stem cells uniteby James GallagherBBC NewsTwo of the holy grails of medicine - stem cell technology and precision gene therapy - have been united for the first time in humans, say scientists.
More on Cash for Eggsby Pete ShanksBiopolitical TimesOctober 13th, 2011The Nuffield Council on Bioethics has issued a report about the provision of human bodily material for medicine and for research, including the issue of payment for gametes.
A Campaign to Allow a Market in Women's Eggs for a New Kind of Cloning Researchby Pete ShanksBiopolitical TimesOctober 7th, 2011An article about a new approach to cloning research was published this week, along with a coordinated and obviously political effort to encourage paying women to undergo egg extraction for research.
High-interest clones[Editorial]NatureOctober 6th, 2011Research into cloned human cells has left the specter of past scientific fraud behind. But reaction to the earlier work still holds worthwhile lessons.
Stem Cell Research Used Cloning Technique, Paid Women for Eggs[Quotes CGS's Marcy Darnovsky]by Eryn BrownLos Angeles TimesOctober 6th, 2011A new study reports a development in stem cell research involving research cloning that relied upon paying women for their eggs.
After Setbacks in Harvesting Stem Cells, a New Approach Shows Promiseby Nicholas WadeNew York TimesOctober 5th, 2011A new study shows promise for stem cell development but also raises concerns, as it paid women $8,000 to donate their eggs, an arduous process.
Women’s health and public interest groups warn against putting women’s health at risk in new kind of research cloningCenter for Genetics and Society, Our Bodies Ourselves, Pro-Choice Alliance for Responsible Research, and Alliance for Humane Biotechnology Question Egg Harvesting for Speculative Research October 5th, 2011"We should not put the health of young women at risk, especially to get raw materials for such exploratory investigations.”
Stem Cells Update: Clinical Trials, Possible Funds, Long-Range Visions and Short-Term Scamsby Pete ShanksBiopolitical TimesSeptember 29th, 2011Embryonic stem cells (ESCs) are edging back into the spotlight, with some tentatively hopeful news, and some schemes, visions, government money and possible scams.
Yet Another Idea for Using Biotechnology to Rescue Endangered Speciesby Pete ShanksBiopolitical TimesSeptember 8th, 2011Scientists have reprogrammed skin cells from two endangered species into stem cells, and hope to use them to generate gametes, which has provoked press speculation.
Government funding reaffirmed for stem cell researchby Eryn BrownLos Angeles TimesJuly 28th, 2011A federal judge rules in favor of an Obama administration policy that expanded such funding, allowing the support to continue.
California agency: Little cells, big salary[Editorial]Los Angeles TimesJuly 7th, 2011The big paycheck of the state's stem cell research agency chief is disturbing, particularly because it's a time when most state agencies are making radical cutbacks.
New Chair for California Stem Cell Agencyby Pete ShanksBiopolitical TimesJune 29th, 2011By a narrow margin, the CIRM board elected financier Jonathan Thomas as Chair, provoking significant criticism over his huge salary.
Investment banker chosen to head state stem cell agencyby Keith DarceSign On San DiegoJune 22nd, 2011An oversight committee of California’s $3 billion stem cell research institute selected Los Angeles investment banker and attorney Jonathan Thomas to be its new chairman.
Missed opportunities at California stem cell research agencyby Michael HiltzikLos Angeles TimesJune 7th, 2011The state agency that funds stem cell research has failed to address criticism that its research is too narrow and its governance overly secretive, and that it has lacked integration with the state's overall research investment.
California stem cell czar offered top pay, asked to name job description by Katie Worth San Francisco ExaminerMay 29th, 2011Exactly what the new leader’s salary will be — and just as importantly, what his role will be — has deeply divided the leadership of the California Institute of Regenerative Medicine.
California officials nominate new board chairman for stem cell agencyby Eryn BrownLos Angeles TimesMay 20th, 2011California Treasurer Bill Lockyer and Gov. Jerry Brown today nominated Jonathan Thomas to succeed Robert Klein as chairman of the governing board.
Setback for New Stem Cell Treatmentby Andrew PollackThe New York TimesMay 13th, 2011Researchers reported on Friday that tissues made from induced pluripotent stem cells might be rejected by a patient’s immune system — even though the tissues would be derived from the same patient.
Stem Cell Strife in US and EU Courtsby Doug PetBiopolitical TimesMay 11th, 2011Developments in US and European courts regarding funding and oversight of stem cell research have reopened passionate debates.
Stem cells: CIRM funds Geron Corp. spinal cord injury trialby Eryn BrownLos Angeles TimesMay 4th, 2011On Wednesday morning the California Institute for Regenerative Medicine announced a $25-million award to support a spinal cord injury trial, the first time that the agency has backed a human clinical trial.
Court Lets U.S. Resume Paying for Embryo Studyby Gardiner HarrisThe New York TimesApril 29th, 2011Government financing of human embryonic stem cell research can continue, a federal appeals court ruled Friday.
Bioethicists Show How to Disagree Without Rancorby Pete ShanksBiopolitical TimesApril 19th, 2011Excerpts of a conversation between Arthur Caplan and Robert P. George demonstrate the possibility of constructive discussions about difficult ethical issues.
Look, no embryos! The future of ethical stem cellsby Alok JhaThe Observer (UK)March 13th, 2011Experts believe that developments in reprogrammed 'iPS' cells will truly revolutionise the treatment of life-threatening illnesses.
California controller Chiang on stem cell agency: 'Let the management manage' by Ron LeutySan Francisco Business TimesMarch 9th, 2011“The (board’s) most important role...is severely compromised when that management includes the (board) chair,” Chiang wrote.
Reprogrammed Stem Cells Are Rife with MutationsThe findings cast doubt on a promising alternative to the use of embryonic stem cells in medicine.by Emily SingerTechnology ReviewMarch 3rd, 2011Two new studies published in Nature suggest that iPS cells may not be as promising for clinical applications as previously hoped.
Animal death toll ends cloning trials [New Zealand]by Kiran ChugThe Dominion PostFebruary 21st, 2011Although cloning trials will no longer be conducted, AgResearch will continue to develop transgenic cattle, sheep and goats.
State stem cell firm uses tax dollars for nonpublic campuses[Quotes CGS's Marcy Darnovsky]by Katie WorthSan Francisco ExaminerFebruary 20th, 2011The Institute's bill for PR is also being called into question, in a time when public resources are especially scarce.
Displaying 1-300 of 1256  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760